Could an allergy drug stop Liver-Related itching?
NCT ID NCT04256759
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This small study tested dupilumab (Dupixent), a drug used for allergies and eczema, in 9 adults with moderate to severe chronic itching from liver disease. Participants received injections every 2 weeks for 18 weeks. The goal was to see if itching scores improved. Because it was an early, open-label trial with no comparison group, results are preliminary.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Dupilumab (Dupixent) injection
- What this could lead to
- If it works, this could point toward a new treatment for severe itching caused by liver disease.
- What could go wrong
- This is a very small, early-phase study with only 9 participants and no placebo group. Results may not apply to everyone, and the drug may not work or could have side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRURITUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mayo Clinic Florida
Jacksonville, Florida, 32224, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a different opioid reduce Post-C-Section itching?
- Can a pill stop the relentless itch of a liver disease? a major trial aims to find out.
- Scientists launch study to unravel mysterious chronic itch
- Dialysis itch relief: could a simple education program be the answer?
- Can cannabis oil stop severe itching? new trial aims to find out
- Can a simple cream soothe psoriasis itch? small trial hopes to find out